Welcome to Eye
Eye is the official journal of The Royal College of Ophthalmologists. It aims to provide the practising ophthalmologist with information on the latest clinical and laboratory-based research.
Free online issue
Volume 23, No 10
October 2009
ISSN: 0950-222X
EISSN: 1476-5454
2008 impact factor 2.064*
17/48 Ophthalmology
Editor-in-Chief:
A J Lotery
*2008 Journal Citation Reports (Thomson Reuters, 2009
FEATURED ARTICLES
CAMBRIDGE OPHTHALMOLOGY SYMPOSIUM
Prospects for gene therapy of inherited retinal diseaseCAMBRIDGE OPHTHALMOLOGY SYMPOSIUM
Prospects for genetic modulation of corneal graft survivalCAMBRIDGE OPHTHALMOLOGY SYMPOSIUM
Replacement of the RPE monolayerCAMBRIDGE OPHTHALMOLOGY SYMPOSIUM
Artificial corneas: a regenerative medicine approachCAMBRIDGE OPHTHALMOLOGY SYMPOSIUM
Current and future prospects for optoelectronic retinal prosthesesEYE's CAMBRIDGE SYMPOSIUM WEB PAGE
The annual Cambridge Symposium brings together leading international scientists and clinicians for in-depth discussions of topical issues in ophthalmology. Visit Eye's Cambridge Symposium web page to view the full archive of Eye issues covering content from past Cambridge Symposia, in addition to details of upcoming Symposia.
PUBLISHING IN EYE AND AUTHOR INSTRUCTIONS
Please note that Eye's Instructions to Authors have changed substantially. Authors are recommended to read Eye's editorial "Publishing in Eye: The current status" (Eye 2007; 21: 1) and Instructions to Authors before submitting a manuscript for publication in the journal.
AGE-RELATED MACULAR DEGENERATION AWARENESS
March was Age-related Macular Degeneration (AMD) awareness month, and in recognition of this Eye brought together its most recent content in the area and made it freely available to all. Visit the site!
-
Research and Reviews
Latest research highlights and reviews from the NPG family of journals
- Hematology: The case against rituximab maintenance - this content is FREE Source: Nature Reviews Clinical Oncology
- Towards a definition of inorganic nanoparticles from an environmental, health and safety perspective - this content is FREE Source: Nature Nanotechnology
- Comparative efficacy and safety of amlodipine/benazepril combination therapy and amlodipine monotherapy in severe hypertension Source: Journal of Human Hypertension

